Synthetic peracetate tea polyphenols as potent proteasome inhibitors and apoptosis inducers in human cancer cells

被引:64
作者
Kuhn, DJ
Lam, WH
Kazi, A
Daniel, KG
Song, SJ
Chow, LMC
Chan, TH
Dou, QP
机构
[1] Wayne State Univ, Sch Med, Barbara Ann Karmanos Canc Inst, Prevent Program, Detroit, MI 48201 USA
[2] Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA
[3] Hong Kong Polytech Univ, Inst Mol Technol Drug Discovery & Synth, Dept Appl Biol & Chem Technol, Hong Kong, Hong Kong, Peoples R China
[4] Hong Kong Polytech Univ, Inst Mol Technol Drug Discovery & Synth, Open Lab Chiral Technol, Hong Kong, Hong Kong, Peoples R China
[5] Hong Kong Polytech Univ, Inst Mol Technol Drug Discovery & Synth, Cent Lab, Hong Kong, Hong Kong, Peoples R China
来源
FRONTIERS IN BIOSCIENCE-LANDMARK | 2005年 / 10卷
关键词
EGCG; polyphenols; pro-drug; proteasome inhibitors; apoptosis;
D O I
10.2741/1595
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
It has been suggested that proteasome activity is essential for tumor cell proliferation and drug resistance development. We have previously shown that natural and synthetic ester bond-containing tea polyphenols are selective inhibitors of the chymotrypsin-like activity of the proteasome. The most abundant catechin in green tea is (-)epigallocatechin-3-gallate [(-)-EGCG], which has been found by many laboratories to exhibit the most potent anticancer activity. We have reported that (-)-EGCG is also the most effective proteasome inhibitor among all the natural green tea catechins tested. Unfortunately, (-)-EGCG is very unstable in neutral and alkaline conditions. In an attempt to increase the stability and thus the efficacy, we synthesized several (-)-EGCG analogs with acetyl protected -OH groups as prodrugs. Here we report, for the first time, that these acetylated synthetic tea analogs are much more potent than natural (-)-EGCG in inhibiting the proteasome in cultured tumor cells. Consistently, these protected analogs showed much higher potency than (-)-EGCG to inhibit proliferation and transforming activity and to induce apoptosis in human leukemic, prostate, breast, and simian virus 40-transformed cells. Additionally, these protected analogs had greatly reduced effects on human normal and non-transformed cells. Therefore, these peracetate protected tea polyphenols are more efficacious than (-)-EGCG and possess great potential to be developed into novel anticancer drugs. Identification of the cytosolic metabolite(s) of peracetate-protected polyphenols in cultured tumor cells and examination of their in vivo tumor growth-inhibitory activity are currently underway in our laboratory.
引用
收藏
页码:1010 / 1023
页数:14
相关论文
共 46 条
[1]   Molecular targets for green tea in prostate cancer prevention [J].
Adhami, VM ;
Ahmad, N ;
Mukhtar, H .
JOURNAL OF NUTRITION, 2003, 133 (07) :2417S-2424S
[2]   (-)-Epigallocatechin-(3)-gallate prevents oxidative damage in both the aqueous and lipid compartments of human plasma [J].
Aldini, G ;
Yeum, KJ ;
Carini, MR ;
Krinsky, NI ;
Russell, RA .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 302 (02) :409-414
[3]   Novel dipeptidyl proteasome inhibitors overcome Bcl-2 protective function and selectively accumulate the cyclin-dependent kinase inhibitor p27 and induce apoptosis in transformed, but not normal, human fibroblasts [J].
An, B ;
Goldfarb, RH ;
Siman, R ;
Dou, QP .
CELL DEATH AND DIFFERENTIATION, 1998, 5 (12) :1062-1075
[4]  
Bladier C, 1997, CELL GROWTH DIFFER, V8, P589
[5]  
Bode AM, 2003, J BIOCHEM MOL BIOL, V36, P66
[6]  
Bravo L, 1998, NUTR REV, V56, P317, DOI 10.1111/j.1753-4887.1998.tb01670.x
[7]   (-)-epigallocatechin gallate causes oxidative damage to isolated and cellular DNA [J].
Furukawa, A ;
Oikawa, S ;
Murata, M ;
Hiraku, Y ;
Kawanishi, S .
BIOCHEMICAL PHARMACOLOGY, 2003, 66 (09) :1769-1778
[8]  
GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0
[9]   Structure of 20S proteasome from yeast at 2.4 angstrom resolution [J].
Groll, M ;
Ditzel, L ;
Lowe, J ;
Stock, D ;
Bochtler, M ;
Bartunik, HD ;
Huber, R .
NATURE, 1997, 386 (6624) :463-471
[10]  
Hideshima T, 2001, CANCER RES, V61, P3071